Search

Your search keyword '"Wong, Raymond Ching Chiew"' showing total 49 results
Start Over Author "Wong, Raymond Ching Chiew"
49 results on '"Wong, Raymond Ching Chiew"'

2. Predictors of Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock despite Intra-Aortic Balloon Pump: Opportunities for Advanced Mechanical Circulatory Support in Asia

Author

Lin, Weiqin, primary, Yip, Alfred Chung Lum, additional, Cherian, Robin, additional, Chan, Siew Pang, additional, Evangelista, Lauren Kay Mance, additional, Sari, Novi Yanti, additional, Ling, Hwei Sung, additional, Lim, Yoke Ching, additional, Wong, Raymond Ching Chiew, additional, Tung, Benjamin Wei Liang, additional, Tan, Li-Ling, additional, Low, Adrian F., additional, Ambhore, Anand Adinath, additional, and Lim, Shir Lynn, additional

Published
2024
Full Text
View/download PDF

3. Migraine and atrial fibrillation: a systematic review and meta-analysis

Author

Lim, Camelia Qi En, primary, Teo, Yao Neng, additional, Li, Tony Yi-Wei, additional, Teo, Yao Hao, additional, Syn, Nicholas Li-Xun, additional, Leow, Aloysius Sheng-Ting, additional, Ho, Jamie Sin-Ying, additional, Lim, Toon Wei, additional, Seow, Swee-Chong, additional, Chan, Mark Yan Yee, additional, Wong, Raymond Ching Chiew, additional, Chai, Ping, additional, Chan, Amanda Chee Yun, additional, Sharma, Vijay Kumar, additional, Tan, Benjamin Yong-Qiang, additional, Yeo, Leonard Leong Litt, additional, Ong, Jonathan Jia Yuan, additional, and Sia, Ching-Hui, additional

Published
2024
Full Text
View/download PDF

6. ASSOCIATION OF LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Author

Sari, Novi Yanti, primary, Li, Tony, additional, Yeo, Selvie, additional, Ngiam, Nicholas, additional, Lee, Ronald Chi Hang, additional, Lee, Edward, additional, Yeo, Tiong Cheng, additional, Yip, James Wei Luen, additional, Poh, Kian Keong, additional, Kong, William K.F., additional, Lim, Yoke-Ching, additional, Lin, Weiqin, additional, Sia, Ching Hui, additional, and Wong, Raymond Ching-Chiew, additional

Published
2023
Full Text
View/download PDF

7. VALIDATION OF RISK STRATIFICATION MODELS FOR SUDDEN CARDIAC DEATH IN MULTI-ETHNIC ASIAN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Author

Li, Tony, primary, Yeo, Selvie, additional, Sari, Novi Yanti, additional, Ngiam, Nicholas, additional, Lee, Chi Hang, additional, Lim, Toon Wei, additional, Yeo, Wee Tiong, additional, Seow, Swee-Chong, additional, Lim, Yoke-Ching, additional, Yeo, Tiong Cheng, additional, Yip, James Wei Luen, additional, Poh, Kian Keong, additional, Kong, William K.F., additional, Lin, Weiqin, additional, Sia, Ching Hui, additional, and Wong, Raymond Ching-Chiew, additional

Published
2023
Full Text
View/download PDF

8. The Singapore Heart Failure Outcomes and Phenotypes (SHOP) Study and Prospective Evaluation of Outcome in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PEOPLE) Study: Rationale and Design

Author

Santhanakrishnan, Rajalakshmi, Ng, Tze P., Cameron, Vicky A., Gamble, Greg D., Ling, Lieng H., Sim, David, Leong, Gerard Kui Toh, Yeo, Poh Shuan Daniel, Ong, Hean Yee, Jaufeerally, Fazlur, Wong, Raymond Ching-Chiew, Chai, Ping, Low, Adrian F., Lund, Mayanna, Devlin, Gerry, Troughton, Richard, Richards, A. Mark, Doughty, Robert N., and Lam, Carolyn S.P.

Published
2013
Full Text
View/download PDF

13. ASSOCIATION BETWEEN CLINICAL CHARACTERISTICS AND THE DEVELOPMENT OF CARDIOGENIC SHOCK IN ASIAN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS

Author

Djohan, Andie Hartanto, primary, Evangelista, Lauren Kay Mance, additional, Sia, Ching Hui, additional, Lin, Weiqin, additional, Chan, Koo Hui, additional, Ching, Lim Yoke, additional, Chan, Mark Y, additional, Cherian, Robin, additional, Wong, Raymond Ching-Chiew, additional, Lee, Ronald Chi Hang, additional, Tung, Benjamin WL, additional, Ng, Zhe Yan, additional, Tan, Huay Cheem, additional, Yeo, Tiong Cheng, additional, Chai, Ping, additional, Low, Adrian, additional, and Loh, Poay Huan, additional

Published
2022
Full Text
View/download PDF

14. ASSOCIATION BETWEEN CLINICAL CHARACTERISTICS AND IMPROVEMENT IN LEFT VENTRICULAR EJECTION FRACTION IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS

Author

Evangelista, Lauren Kay M., primary, Djohan, Andie Hartanto, additional, Sia, Ching Hui, additional, Tan, Sarah Ming Li, additional, Low, Adrian, additional, Lim, Yoke-Ching, additional, Chan, Mark, additional, Cherian, Robin, additional, Wong, Raymond Ching-Chiew, additional, Lee, Chi-Hang, additional, Ng, Perryn, additional, Yeo, Tiong-Cheng, additional, Chai, Ping, additional, Tan, Huay-Cheem, additional, Lin, Weiqin, additional, and Loh, Poay Huan, additional

Published
2022
Full Text
View/download PDF

16. COMPARING SGLT2 INHIBITORS AGAINST SACUBITRIL/VALSARTAN IN HEART FAILURE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Author

Teo, Yao Neng, primary, Teo, Yao Hao, additional, Syn, Nicholas L., additional, Yoong, Celine Shuen Yin, additional, Cheong, Alex Jia Yang, additional, Wee, Caitlin Fern, additional, Lim, Yoke-Ching, additional, Lee, Chi-Hang, additional, Yeo, Tiong Cheng, additional, Chai, Ping, additional, Wong, Raymond Ching-Chiew, additional, Lim, Weiqin, additional, and Sia, Ching Hui, additional

Published
2022
Full Text
View/download PDF

26. Single‐dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo‐controlled study (PRACTICE‐ASIA‐HF)

Author

Yeo, Tee Joo, Yeo, Poh Shuan Daniel, Hadi, Farid Abdul, Cushway, Timothy, Lee, Kim Yee, Yin, Fang Fang, Ching, Anne, Li, Ruili, Loh, Seet Yoong, Lim, Shir Lynn, Wong, Raymond Ching‐Chiew, Tai, Bee Choo, Richards, Arthur Mark, and Lam, Carolyn S.P.

Subjects
Heart Failure, Male, Singapore, Time Factors, Anemia, Iron-Deficiency, Dose-Response Relationship, Drug, Iron deficiency, Iron, Pilot Projects, Stroke Volume, Middle Aged, Ferric carboxymaltose, Ferric Compounds, Treatment Outcome, Southeast Asian heart failure, Double-Blind Method, Original Research Articles, Injections, Intravenous, Prevalence, Humans, Female, Original Research Article, Maltose, Follow-Up Studies, Retrospective Studies
Abstract

Aims Iron deficiency is highly prevalent in Southeast Asians with heart failure (HF) and associated with worse outcomes. This trial aimed to assess the effect of intravenous iron in Southeast Asians hospitalized with decompensated HF. Methods and results Fifty patients hospitalized for acute decompensated HF, regardless of ejection fraction, with iron deficiency (defined as serum ferritin

Published
2018

31. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

Author

Packer, Milton, Mcmurray, John J. V., Desai, Akshay S., Gong, Jianjian, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael, Andersen, Karl, Arango, Juan Luis, Arnold, J. Malcolm, Belohlávek, Jan, Böhm, Michael, Boytsov, Sergey, Burgess, Lesley J., Cabrera, Walter, Calvo, Carlos, Chen, Chen Huan, Dukat, Andrej, Duarte, Yan Carlos, Erglis, Andrejs, Michael, Fu, Gomez, Efrain, Gonzàlez Medina, Angel, Hagège, Albert A., Huang, Jun, Katova, Tzvetana, Kiatchoosakun, Songsak, Kim, Kee Sik, Kozan, Ömer, Llamas, Edmundo Bayram, Martinez, Felipe, Merkely, Bela, Mendoza, Iván, Mosterd, Arend, Negrusz Kawecka, Marta, Peuhkurinen, Keijo, Ramires, Felix J. A., Refsgaard, Jens, Rosenthal, Arvo, Senni, Michele, Sibulo, Antonio S., Silva Cardoso, José, Squire, Iain B., Starling, Randall C., Teerlink, John R., Vanhaecke, Johan, Vinereanu, Dragos, Wong, Raymond Ching Chiew, PARADIGM HF Investigators, Coordinators, Lembo, Giuseppe, Neyses, Ludwig [collaborator], Packer, M, Mcmurray, J, Desai, A, Gong, J, Lefkowitz, M, Rizkala, A, Rouleau, J, Shi, V, Solomon, S, Swedberg, K, Zile, M, Andersen, K, Arango, J, Arnold, J, Belohlavek, J, Bohm, M, Boytsov, S, Burgess, L, Cabrera, W, Calvo, C, Chen, C, Dukat, A, Duarte, Y, Erglis, A, Fu, M, Gomez, E, Gonzalez-Medina, A, Hagege, A, Huang, J, Katova, T, Kiatchoosakun, S, Kim, K, Kozan, O, Llamas, E, Martinez, F, Merkely, B, Mendoza, I, Mosterd, A, Negrusz-Kawecka, M, Peuhkurinen, K, Ramires, F, Refsgaard, J, Rosenthal, A, Senni, M, Jr, A, Silva-Cardoso, J, Squire, I, Starling, R, Teerlink, J, Vanhaecke, J, Vinereanu, D, and Wong, R

Subjects
Angiotensin receptor, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], receptors, Tetrazoles, heart failure, Angiotensin-Converting Enzyme Inhibitors, Kaplan-Meier Estimate, Sacubitril, Angiotensin, Heart failure, Neprilysin, Receptors, Aminobutyrates, Angiotensin Receptor Antagonists, Biomarkers, Double-Blind Method, Enalapril, Heart Failure, Humans, Natriuretic Peptide, Brain, Peptide Fragments, Risk Factors, Stroke Volume, Survivors, Treatment Outcome, Troponin, Disease Progression, Medicine (all), Cardiology and Cardiovascular Medicine, Physiology (medical), Enalapril/therapeutic use, Heart Failure/blood, Receptor, Systèmes cardiovasculaire & respiratoire [D03] [Sciences de la santé humaine], Troponin/blood, Angiotensin Receptor Antagonists/therapeutic use, Drug Combinations, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Tetrazoles/therapeutic use, Cardiology, Valsartan, Heart Failure/blood/drug therapy/physiopathology, medicine.drug, medicine.medical_specialty, neprilysin, receptors, angiotensin, Internal medicine, Renin–angiotensin system, medicine, heart failure, neprilysin, receptors, angiotensin, business.industry, Biphenyl Compounds, medicine.disease, Endocrinology, Aminobutyrates/therapeutic use, Stroke Volume/physiology, Natriuretic Peptide, Brain/blood, Cardiovascular & respiratory systems [D03] [Human health sciences], business, Neprilysin/antagonists & inhibitors, Peptide Fragments/blood, Sacubitril, Valsartan, Biomarkers/blood
Abstract

Background— Clinical trials in heart failure have focused on the improvement in symptoms or decreases in the risk of death and other cardiovascular events. Little is known about the effect of drugs on the risk of clinical deterioration in surviving patients. Methods and Results— We compared the angiotensin-neprilysin inhibitor LCZ696 (400 mg daily) with the angiotensin-converting enzyme inhibitor enalapril (20 mg daily) in 8399 patients with heart failure and reduced ejection fraction in a double-blind trial. The analyses focused on prespecified measures of nonfatal clinical deterioration. In comparison with the enalapril group, fewer LCZ696-treated patients required intensification of medical treatment for heart failure (520 versus 604; hazard ratio, 0.84; 95% confidence interval, 0.74–0.94; P =0.003) or an emergency department visit for worsening heart failure (hazard ratio, 0.66; 95% confidence interval, 0.52–0.85; P =0.001). The patients in the LCZ696 group had 23% fewer hospitalizations for worsening heart failure (851 versus 1079; P P =0.005), to receive intravenous positive inotropic agents (31% risk reduction, P P =0.07). The reduction in heart failure hospitalization with LCZ696 was evident within the first 30 days after randomization. Worsening of symptom scores in surviving patients was consistently more common in the enalapril group. LCZ696 led to an early and sustained reduction in biomarkers of myocardial wall stress and injury (N-terminal pro–B-type natriuretic peptide and troponin) versus enalapril. Conclusions— Angiotensin-neprilysin inhibition prevents the clinical progression of surviving patients with heart failure more effectively than angiotensin-converting enzyme inhibition. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT01035255.

Published
2015
Full Text
View/download PDF

34. Geographic variations in the PARADIGM-HF heart failure trial

Author

Kristensen, Søren Lund, primary, Martinez, Felipe, additional, Jhund, Pardeep S., additional, Arango, Juan Luis, additional, Bĕlohlávek, Jan, additional, Boytsov, Sergey, additional, Cabrera, Walter, additional, Gomez, Efrain, additional, Hagège, Albert A., additional, Huang, Jun, additional, Kiatchoosakun, Songsak, additional, Kim, Kee-Sik, additional, Mendoza, Iván, additional, Senni, Michele, additional, Squire, Iain B., additional, Vinereanu, Dragos, additional, Wong, Raymond Ching-Chiew, additional, Gong, Jianjian, additional, Lefkowitz, Martin P., additional, Rizkala, Adel R., additional, Rouleau, Jean L., additional, Shi, Victor C., additional, Solomon, Scott D., additional, Swedberg, Karl, additional, Zile, Michael R., additional, Packer, Milton, additional, and McMurray, John J.V., additional

Published
2016
Full Text
View/download PDF

35. How adults with cardiac conditions in Singapore understand the Patient Activation Measure (PAM-13) items: a cognitive interviewing study.

Author

Ngooi, Bi Xia, Packer, Tanya L., Warner, Grace, Kephart, George, Koh, Karen Wei Ling, Wong, Raymond Ching Chiew, and Lim, Serene Peiying

Subjects
HEART disease diagnosis, BIOLOGICAL models, COGNITIVE testing, TEST validity, RESEARCH methodology, PATIENT education, HEALTH self-care, CULTURAL competence, RETROSPECTIVE studies, DATA analysis software
Abstract

Purpose:Validation studies of the PAM-13 have found differences in scale performance, suggesting that health beliefs embedded in different cultures and/or self-management needs of different client groups influence how people respond to the items. The purpose of this study was to examine how adults with cardiac conditions in Singapore interpreted and responded to the PAM-13, to investigate possible reasons for differences in responses and to propose solutions to overcome them. Methods:We conducted retrospective cognitive interviews with 13 participants in an out-patient heart center. Interviews were transcribed and analyzed based on the framework approach to qualitative analysis. The four stages from Tourangeau’s cognitive model were used as a framework to index the data from each item. Results:There was variation in comprehension of questions leading to variation in responses. Comprehension issues were due to terms perceived by participants to be vague and the use of English terms uncommon in Singapore. Cultural influences impacted decision processes and problems with response processes of the self-rating Likert scale surfaced. Conclusions:This study reinforces the need to culturally adapt the tool, even when language translation is not necessary. Providing Likert scales with a larger number of may widen the relevance of PAM-13 in Singapore.Implications for rehabilitationNeed to culturally adapt assessment tool, even when language translation is not necessary.Consider using Likert scales with a larger number of categories when using in Asian countries such as Singapore.Caution must be taken when using PAM-13 levels to decide interventions for each individual. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

36. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Author

Neyses, Ludwig [collaborator], Packer, Milton, McMurray, John J. V., Desai, Akshay S., Gong, Jianjian, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael, Andersen, Karl, Arango, Juan Luis, Arnold, J. Malcolm, Belohlavek, Jan, Bohm, Michael, Boytsov, Sergey, Burgess, Lesley J., Cabrera, Walter, Calvo, Carlos, Chen, Chen-Huan, Dukat, Andrej, Duarte, Yan Carlos, Erglis, Andrejs, Fu, Michael, Gomez, Efrain, Gonzalez-Medina, Angel, Hagege, Albert A., Huang, Jun, Katova, Tzvetana, Kiatchoosakun, Songsak, Kim, Kee-Sik, Kozan, Omer, Llamas, Edmundo Bayram, Martinez, Felipe, Merkely, Bela, Mendoza, Ivan, Mosterd, Arend, Negrusz-Kawecka, Marta, Peuhkurinen, Keijo, Ramires, Felix J. A., Refsgaard, Jens, Rosenthal, Arvo, Senni, Michele, Sibulo, Antonio S. Jr, Silva-Cardoso, Jose, Squire, Iain B., Starling, Randall C., Teerlink, John R., Vanhaecke, Johan, Vinereanu, Dragos, Wong, Raymond Ching-Chiew, Neyses, Ludwig [collaborator], Packer, Milton, McMurray, John J. V., Desai, Akshay S., Gong, Jianjian, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael, Andersen, Karl, Arango, Juan Luis, Arnold, J. Malcolm, Belohlavek, Jan, Bohm, Michael, Boytsov, Sergey, Burgess, Lesley J., Cabrera, Walter, Calvo, Carlos, Chen, Chen-Huan, Dukat, Andrej, Duarte, Yan Carlos, Erglis, Andrejs, Fu, Michael, Gomez, Efrain, Gonzalez-Medina, Angel, Hagege, Albert A., Huang, Jun, Katova, Tzvetana, Kiatchoosakun, Songsak, Kim, Kee-Sik, Kozan, Omer, Llamas, Edmundo Bayram, Martinez, Felipe, Merkely, Bela, Mendoza, Ivan, Mosterd, Arend, Negrusz-Kawecka, Marta, Peuhkurinen, Keijo, Ramires, Felix J. A., Refsgaard, Jens, Rosenthal, Arvo, Senni, Michele, Sibulo, Antonio S. Jr, Silva-Cardoso, Jose, Squire, Iain B., Starling, Randall C., Teerlink, John R., Vanhaecke, Johan, Vinereanu, Dragos, and Wong, Raymond Ching-Chiew

Abstract

BACKGROUND: Clinical trials in heart failure have focused on the improvement in symptoms or decreases in the risk of death and other cardiovascular events. Little is known about the effect of drugs on the risk of clinical deterioration in surviving patients. METHODS AND RESULTS: We compared the angiotensin-neprilysin inhibitor LCZ696 (400 mg daily) with the angiotensin-converting enzyme inhibitor enalapril (20 mg daily) in 8399 patients with heart failure and reduced ejection fraction in a double-blind trial. The analyses focused on prespecified measures of nonfatal clinical deterioration. In comparison with the enalapril group, fewer LCZ696-treated patients required intensification of medical treatment for heart failure (520 versus 604; hazard ratio, 0.84; 95% confidence interval, 0.74-0.94; P=0.003) or an emergency department visit for worsening heart failure (hazard ratio, 0.66; 95% confidence interval, 0.52-0.85; P=0.001). The patients in the LCZ696 group had 23% fewer hospitalizations for worsening heart failure (851 versus 1079; P<0.001) and were less likely to require intensive care (768 versus 879; 18% rate reduction, P=0.005), to receive intravenous positive inotropic agents (31% risk reduction, P<0.001), and to have implantation of a heart failure device or cardiac transplantation (22% risk reduction, P=0.07). The reduction in heart failure hospitalization with LCZ696 was evident within the first 30 days after randomization. Worsening of symptom scores in surviving patients was consistently more common in the enalapril group. LCZ696 led to an early and sustained reduction in biomarkers of myocardial wall stress and injury (N-terminal pro-B-type natriuretic peptide and troponin) versus enalapril. CONCLUSIONS: Angiotensin-neprilysin inhibition prevents the clinical progression of surviving patients with heart failure more effectively than angiotensin-converting enzyme inhibition. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifi

Published
2015
Full Text
View/download PDF

37. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction

Author

Chan, Michelle M.Y., primary, Santhanakrishnan, Rajalakshmi, additional, Chong, Jenny P.C., additional, Chen, Zhaojin, additional, Tai, Bee Choo, additional, Liew, Oi Wah, additional, Ng, Tze Pin, additional, Ling, Lieng H., additional, Sim, David, additional, Leong, Kui Toh G., additional, Yeo, Poh Shuan Daniel, additional, Ong, Hean-Yee, additional, Jaufeerally, Fazlur, additional, Wong, Raymond Ching-Chiew, additional, Chai, Ping, additional, Low, Adrian F., additional, Richards, Arthur M., additional, and Lam, Carolyn S.P., additional

Published
2015
Full Text
View/download PDF

45. ASSOCIATION OF LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY.

Author

Li, Tony, Sari, Novi Yanti, Yeo, Selvie, Lee, Chi Hang, Lee, Edward, Yeo, Tiong Cheng, Yip, James Wei Luen, Poh, Kian Keong, Kong, William K.F., Lim, Yoke-Ching, Lin, Weiqin, Sia, Ching Hui, and Wong, Raymond Ching-Chiew

Subjects
*GLOBAL longitudinal strain, *HYPERTROPHIC cardiomyopathy, *TREATMENT effectiveness
Published
2024
Full Text
View/download PDF

46. H2FPEF SCORE IN HYPERTROPHIC CARDIOMYOPATHY.

Author

Laenens, Dorien, Zegkos, Thomas, Sia, Ching Hui, Kamperidis, Vasileios, Tjahjadi, Catherina, Wong, Raymond Ching-Chiew, Li, Tony, Efthimiadis, Georgios, Kong, William KF, Poh, Kian Keong, Ziakas, Antonios, Bax, Jeroen J., and Marsan, Nina Ajmone

Subjects
*HYPERTROPHIC cardiomyopathy
Published
2024
Full Text
View/download PDF

47. Atretic aortic valvular cusp causing severe aortic regurgitation.

Author

Wong RC, Yip JWL, Tay ELW, and Kong WKF

Subjects
Aortic Valve diagnostic imaging, Aortography methods, Computed Tomography Angiography methods, Heart Murmurs diagnosis, Heart Murmurs etiology, Humans, Male, Rare Diseases, Severity of Illness Index, Stroke Volume physiology, Young Adult, Aortic Valve abnormalities, Aortic Valve Insufficiency diagnostic imaging, Cardiac Output, Low diagnostic imaging, Echocardiography, Transesophageal methods, Heart Defects, Congenital diagnostic imaging
Published
2018
Full Text
View/download PDF

48. Transitional Care to Reduce Heart Failure Readmission Rates in South East Asia.

Author

Chan WX, Lin W, and Wong RCC

Abstract

Heart failure (HF) is an emerging public health problem due to increasing hospitalisations, readmissions and direct healthcare costs. Transitional care (TC) aims to improve multidisciplinary care coordination in HF and provides a streamlined strategy to ensure discharge success. This article reviews the different TC models and interventions in HF, and compares their strengths, weaknesses and efficacies. Notably, a nurse-led TC model under the direct administration of a dedicated multidisciplinary team appears to be the superior model of care. The emerging use of remote technology to track patient progress adds value, as human resources are scarce. Several knowledge gaps are highlighted in this article. The authors share their local institutional TC experience and discuss its early impact on HF care., Competing Interests: Disclosure: The authors have no conflicts of interest to declare.

Published
2016
Full Text
View/download PDF

49. Asymmetric left ventricular hypertrophy associated with morbid obesity mimicking familial hypertrophic cardiomyopathy.

Author

Wong RC and Tan KB

Subjects
Adult, Cardiomyopathy, Hypertrophic, Familial, Diagnosis, Differential, Echocardiography, Humans, Male, Hypertrophy, Left Ventricular complications, Hypertrophy, Left Ventricular diagnosis, Obesity, Morbid complications
Abstract

Asymmetric septal hypertrophy with systolic anterior motion of the mitral valve is frequently a phenotypic, but not pathognomonic, expression of genetic hypertrophic cardiomyopathy (HCM) with or without obstruction. It can, however, be associated nonspecifically with other forms of increased left ventricular (LV) afterload. We herein report the case of a young man with obesity cardiomyopathy and heart failure who presented with asymmetric septal hypertrophy and marked LV hypertrophy, and endomyocardial biopsy ruled out genetic HCM.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results